Pinpoint Science and Analog Devices to Develop and Build Nanosensor Diagnostics
Startup Sandbox graduate joins with semiconductor giant to develop low-cost instruments that diagnose infectious diseases
25 Feb 2020
Pinpoint Science, a Startup Sandbox graduate company, and Analog Devices have announced they are collaborating on the development of nanosensor diagnostics that aim to deliver lab-accurate results in under a minute. Such devices are expected to transform how infectious diseases are diagnosed worldwide.
Today, few cost-effective, handheld field diagnostic tools exist that do more than detect skin temperature. The coronavirus has spotlighted the urgent need for better methods of mass screening populations to contain the spread of diseases that threaten humanity on a planetary level. Such mass screening devices can be deployed in the field rather than requiring hospital visits and clinical tests that take hours and are too slow and too expensive to impact the spread of highly contagious diseases.
“Our collaboration with a world-class semiconductor manufacturer like ADI means we can begin to realize the potential of our groundbreaking technology... We are developing a low-cost, high-speed handheld screening test that can be rapidly deployed as a critical weapon to address emerging global disease threats.” Lisa Diamond CEO, Pinpoint Science
Pinpoint’s nanosensors are to be manufactured using the advanced fabrication capabilities that have made Analog Devices a world leader in the design and manufacturing of analog, mixed signal, and DSP integrated circuits.
“Analog Devices believes Pinpoint’s novel nanosensor technology holds great promise for a wide range of applications, especially for rapid, low-cost pathogen detection, and we look forward to a long and fruitful collaboration with Pinpoint in bringing this breakthrough technology to market.” Nimrode Moreshet Director of Emerging Business at Analog Devices
For more details, see this article at Santa Cruz Tech Beat.